chevron_leftBack
As of 24 April 2025, MPH Health Care AG has a market cap of $115.96M USD, ranking #19884 globally and #253 in Germany. It ranks #2032 in the Financial Services sector, and #300 in the Asset Management industry.
Key Stats
Market Cap
$115.96MUSD
102.33M EUR
Enterprise Value
$117.1MUSD
103.33M EUR
Revenue (TTM)
$134.0MUSD
118.24M EUR
EBITDA (TTM)
$132.79MUSD
117.17M EUR
Net Income (TTM)
$135.4MUSD
119.48M EUR
EBITDA Margin
99%
Profit Margin
101%
PE Ratio
0.9
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Asset Management
CEO
Patrick Brenske
open_in_new
Employees
2
Founded
2008
Website
mph-ag.de
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.4% | 3.9% | 4.4% | 1.7% | -2.5% | 11% |
Upcoming Earnings
Earnings Date
Wed, Apr 30
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
93M1
ISIN: DE000A289V03
Shares Out.:
Shares Outstanding:
4.281M1
Shares Float:
1.713M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
23.90 EUR | |
|
0W1Q
ISIN: DE000A289V03
Shares Out.:
Shares Outstanding:
4.281M1
Shares Float:
1.713M2
|
24.50 EUR | |
|
93M1
ISIN: DE000A289V03
|
23.90 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company also focuses on therapies for cancer, HIV, rheumatology, and other chronic diseases. In addition, the company offers plastic and aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and specialist medical centres. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany.
